Statins in neurological disorders: an overview and update

Area of Science:

• Neurology
• Pharmacology
• Cardiovascular Medicine

Background:

• Statins are primarily known for lowering cholesterol and preventing coronary heart disease.
• Emerging evidence suggests statins possess additional properties beneficial for neurological health.
• These properties include endothelial protection, antioxidant, anti-inflammatory, and anti-platelet effects.

Purpose of the Study:

• To explore the potential therapeutic applications of statins in various neurological diseases.
• To review the neuroprotective efficacy of statins in conditions such as stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and brain tumors.

Main Methods:

• Review of clinical and preclinical studies on statin efficacy in neurological disorders.
• Analysis of statins' mechanisms of action beyond lipid-lowering.

Main Results:

• Statins demonstrate potential neuroprotective effects across multiple central nervous system disorders.
• Evidence suggests benefits for stroke, Alzheimer's, Parkinson's, multiple sclerosis, and primary brain tumors.
• Most patients with CNS disorders may benefit from lipid-lowering therapy.

Conclusions:

• Statins offer a potential therapeutic target for neurological diseases due to their pleiotropic effects.
• While promising, the unequivocal effectiveness and safety of statins in these conditions require further validation through in vivo studies and clinical trials.
• Adverse effects of lipid-lowering therapy must be considered in the context of neurological treatment.